EF24

Biorbyt

EF24

10

342808-40-6

Research Use Only

C19H15NOF2

311.3253

EF24 is a curcumin analogue with greater anti-tumor efficacy and oral bioavailability via deactivation of the MAPK/ERK signaling pathway in oral squamous cell carcinoma (OSCC). EF24 treatment increases the levels of activated caspase 3 and 9, and decreases the phosphorylated forms of MEK1 and ERK.

FC1C=CC=CC=1/C=C1/C(=O)/C(=C\C2C=CC=CC=2F)/CNC/1

12352200